Eli Lilly & Co. vs. MoonLake Immunotherapeutics Class A Ordinary Shares
LLY
Eli Lilly & Co.
$1306.69 +2.83%
VS MLTXMoonLake Immunotherapeutics Class A Ordinary Shares
$12.34 +15.87%
Eli Lilly & Co. and MoonLake Immunotherapeutics Class A Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | MLTX | |
|---|---|---|
| Market Cap | $1.13 trillion | $906.39 million |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | MLTX | |
|---|---|---|
| Dividend Yield | 0.53% | — |
LLY and MLTX split the dividend factors evenly.
Risk & Sentiment
| LLY | MLTX | |
|---|---|---|
| Short Interest | 1.29% | 0.05% |
MLTX leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, MLTX overview, MLTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.